INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,923 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
42
MP
Menell Richard PeterDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$33K
15.0K sh
Jun 30, 2026Jul 1, 2026
Page 596 of 1724
← PrevNext →
traded Jun 30, 2026
+1d
SEC Form 4

Evidence

39
LJ
Linz Terrence JamesPresident, Wholesale Brands
LZBLA-Z-BOY INC
Open-market sale
SELL$101K
2,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$116K
25.9K sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

39
CJ
Cicco Martin JDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$447
2 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

39
BF
Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$72K
21.2K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

39
CJ
Cicco Martin JDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$2,901
13 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

36
TE
Tamayo Louis EdwardChief Financial Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,641 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

36
ZE
Zafrani EdenCHRO
NYAXNayax Ltd.
Open-market sale
SELL$32K
500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$447
2 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$18K
80 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
JP
Jones Nina PDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$9,149
41 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$670
3 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

35
RP
Roe PeggyDirector
SPGSIMON PROPERTY GROUP INC.
Open-market purchase
BUY$1,340
6 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

32
BD
Berho Carranza Lorenzo DominiqueChief Executive Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$21K
4,666 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

32
BM
Berho Corona Lorenzo ManuelDirector
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$171K
50.0K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

32
BD
Berho Carranza DiegoChief Portfolio Officer
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$12K
3,500 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

29
PJ
Panda Alex JosephEVP, Treasurer, Secretary, CFO
CMTCORE MOLDING TECHNOLOGIES INC
Open-market purchase
BUY$6,487
275 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

28
GA
Greenway AnthonyChief Accounting Officer
KLARKlarna Group plc
Option exercise
M—
526 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
SY
Shaer YaronChief Technology Officer
KLARKlarna Group plc
Option exercise
M—
48 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
SD
Sandstrom DavidChief Marketing Officer
KLARKlarna Group plc
Option exercise
M—
61 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
SD
Sykes DavidChief Commercial Officer
KLARKlarna Group plc
Option exercise
M—
238 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

24
HC
Hunsinger T. CharlesChief Information Officer
SVVSavers Value Village, Inc.
Option exercise
M$207K
20.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

24
GC
Giesecke CamillaChief Operating Officer
KLARKlarna Group plc
Option exercise
M—
41 sh
May 6, 2026Jul 1, 2026
traded May 6, 2026
+56dSEC Form 4

Evidence

22
BH
Blumenthal Neil HarrisDirector, Co-Chief Executive Officer
WRBYWarby Parker Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
36.3K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
SY
Shaer YaronChief Technology Officer
KLARKlarna Group plc
Grant or award
A—
13.7K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
WM
Wesolowski John MPrincipal Accounting Officer
INTSINTENSITY THERAPEUTICS, INC.
Grant or award
A$13K
3,688 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
HM
Harari MicheleDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
KY
Kuo Hui YingDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
PD
Paul Josh D.Chief Accounting Officer
PANWPalo Alto Networks Inc
Open-market sale · 10b5-1 plan
SELL$311K
900 sh
Jul 1, 2026Jul 1, 2026
traded Jul 1, 2026
+0dSEC Form 4

Evidence

21
SD
Sandstrom DavidChief Marketing Officer
KLARKlarna Group plc
Grant or award
A—
13.7K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
CS
Casey SaoriDirector
APPFAPPFOLIO INC
Grant or award
A—
1,110 sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
MB
McGee Grant BExecutive Officer
TGTTARGET CORP
Grant or award
A—
15.3K sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BP
Bhalla Narinder PalChief Medical Officer
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
55.0K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
AN
Ahuja NitaDirector
ABTABBOTT LABORATORIES
Grant or award
A$31K
347 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BB
Brewer BradyDirector
GAPGAP INC
Grant or award
A—
9,903 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
BF
Barone FrancescaChief Scientific Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$236K
23.4K sh
Jun 29, 2026Jul 1, 2026
traded Jun 29, 2026
+2dSEC Form 4

Evidence

21
KH
King Wen-Herng HenryDirector
CVCapsoVision, Inc
Option exercise
M—
2,022 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence

21
WA
Weber AndrewEVP, Technology and Operations
WLYWLYBJOHN WILEY & SONS, INC.
Option exercise
M—
6,631 sh
Jun 30, 2026Jul 1, 2026
traded Jun 30, 2026
+1dSEC Form 4

Evidence